These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30220979)

  • 1. Correction:
    Mellai M; Cattaneo M; Storaci AM; Annovazzi L; Cassoni P; Melcarne A; De Blasio P; Schiffer D; Biunno I
    Oncotarget; 2018 Aug; 9(66):32731. PubMed ID: 30220979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy.
    Mellai M; Cattaneo M; Storaci AM; Annovazzi L; Cassoni P; Melcarne A; De Blasio P; Schiffer D; Biunno I
    Oncotarget; 2015 May; 6(14):12452-67. PubMed ID: 25948789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Glioblastoma and glioblastoma stem cells are dependent on functional MTH1.
    Pudelko L; Rouhi P; Sanjiv K; Gad H; Kalderén C; Höglund A; Squatrito M; Schuhmacher AJ; Edwards S; Hägerstrand D; Berglund UW; Helleday T; Bräutigam L
    Oncotarget; 2020 Feb; 11(8):827. PubMed ID: 32166004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Inhibition of ATM kinase upregulates levels of cell death induced by cannabidiol and γ-irradiation in human glioblastoma cells.
    Ivanov VN; Wu J; Wang TJC; Hei TK
    Oncotarget; 2019 Dec; 10(65):7012-7013. PubMed ID: 31857855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: Increased expression of SKP2 is an independent predictor of locoregional recurrence in cervical cancer via promoting DNA-damage response after irradiation.
    Fu HC; Yang YC; Chen YJ; Lin H; Ou YC; Chien CC; Huang EY; Huang HY; Lan J; Chi HP; Huang KE; Kang HY
    Oncotarget; 2017 Aug; 8(33):55767. PubMed ID: 28903460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma.
    Ohmoto A; Suzuki M; Takai E; Rokutan H; Fujiwara Y; Morizane C; Yanagihara K; Shibata T; Yachida S
    Oncotarget; 2019 Sep; 10(52):5494. PubMed ID: 31534635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation.
    Khatri A; Gu JJ; McKernan CM; Xu X; Pendergast AM
    Oncotarget; 2019 Oct; 10(57):6045-6046. PubMed ID: 31666936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatment.
    Zhang H; Zhan C; Ke J; Xue Z; Zhang A; Xu K; Shen Z; Yu L; Chen L
    Oncotarget; 2018 Oct; 9(81):35285. PubMed ID: 30443297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Infiltrating mast cells increase prostate cancer chemotherapy and radiotherapy resistances via modulation of p38/p53/p21 and ATM signals.
    Xie H; Li C; Dang Q; Chang LS; Li L
    Oncotarget; 2019 Jun; 10(39):3978. PubMed ID: 31231473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget.
    Qiu YQ; Yang CW; Lee YZ; Yang RB; Lee CH; Hsu HY; Chang CC; Lee SJ
    Oncotarget; 2019 Aug; 10(47):4919. PubMed ID: 31448057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer.
    Sugase T; Takahashi T; Serada S; Fujimoto M; Ohkawara T; Hiramatsu K; Koh M; Saito Y; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Hanazaki K; Mori M; Doki Y; Naka T
    Oncotarget; 2021 Oct; 12(21):2232-2233. PubMed ID: 34676057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01).
    Kim HR; Jang JS; Sun JM; Ahn MJ; Kim DW; Jung I; Lee KH; Kim JH; Lee DH; Kim SW; Cho BC
    Oncotarget; 2017 Aug; 8(33):55766. PubMed ID: 28903459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Development and validation of nomograms for predicting survival in patients with non-metastatic colorectal cancer.
    Jiang H; Tang E; Xu D; Chen Y; Zhang Y; Tang M; Xiao Y; Zhang Z; Deng X; Li H; Lin M
    Oncotarget; 2018 Oct; 9(82):35373. PubMed ID: 30450164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia.
    Sun H; Lin DC; Guo X; Masouleh BK; Gery S; Cao Q; Alkan S; Ikezoe T; Akiba C; Paquette R; Chien W; Müller-Tidow C; Jing Y; Agelopoulos K; Müschen M; Koeffler HP
    Oncotarget; 2017 Sep; 8(38):64651. PubMed ID: 28969101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum: Targeting Metabolic Remodeling in Glioblastoma Multiforme.
    Wolf A; Agnihotri S; Guha A
    Oncotarget; 2018 Oct; 9(78):34855. PubMed ID: 30410682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice.
    Reeves PM; Abbaslou MA; Kools FRW; Vutipongsatorn K; Tong X; Gavegnano C; Schinazi RF; Poznansky MC
    Oncotarget; 2018 Jul; 9(54):30472. PubMed ID: 30101001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: Molecular response prediction in CML: novel ideas?
    Wolf D; Sopper S
    Oncotarget; 2018 Nov; 9(88):35871. PubMed ID: 30533202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1.
    Sekihara K; Saitoh K; Han L; Ciurea S; Yamamoto S; Kikkawa M; Kazuno S; Taka H; Kaga N; Arai H; Miida T; Andreeff M; Konopleva M; Tabe Y
    Oncotarget; 2019 Nov; 10(63):6842. PubMed ID: 31827726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: γKlotho is a novel marker and cell survival factor in a subset of triple negative breast cancers.
    Trošt N; Peña-Llopis S; Koirala S; Stojan J; Potts PR; Fon Tacer K; Martinez ED
    Oncotarget; 2019 Jan; 10(8):916. PubMed ID: 30783519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes.
    Cedena MT; Rapado I; Santos-Lozano A; Ayala R; Onecha E; Abaigar M; Such E; Ramos F; Cervera J; Díez-Campelo M; Sanz G; Rivas JH; Lucía A; Martínez-López J
    Oncotarget; 2018 Jul; 9(56):30936. PubMed ID: 30112119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.